Adult chamber hypertrophy reflects chronic pressure overload (concentric hypertrophy) or volume overload (eccentric dilatation) resulting from systemic hypertension, valvular heart disease, or cardiomyopathies.
1. Atrial Enlargement & Interatrial Conduction Blocks
| Condition | Lead II Electrocardiographic Criteria | Lead $V_1$ Electrocardiographic Criteria | Clinical Significance |
|---|---|---|---|
| Right Atrial Enlargement (RAE / P-Pulmonale) | Tall peaked P wave $> 2.5\text{ mm } (0.25\text{ mV})$. | Positive deflection of P wave $> 1.5\text{ mm}$. | COPD, Pulmonary Embolism, Tricuspid regurgitation, Pulmonary Hypertension. |
| Left Atrial Enlargement (LAE / P-Mitrale) | Broad, notched P wave duration $\ge 0.12\text{ s}$ with inter-peak notch $>0.04\text{ s}$. | Deep terminal negative component $> 1\text{ mm}$ deep and $> 0.04\text{ s}$ wide (Morris Index). | Mitral stenosis, severe systemic hypertension, LV diastolic dysfunction. |
| Interatrial Block (Bayés Syndrome) | P-wave duration $\ge 120\text{ ms}$ with biphasic (+/-) morphology in inferior leads (II, III, aVF). | Biphasic P wave with terminal negativity. | Conduction delay across Bachmann's Bundle; powerful predictor of paroxysmal Atrial Fibrillation and cardioembolic stroke. |
2. Left Ventricular Hypertrophy (LVH) Criteria
| Diagnostic Voltage / Point System | Quantitative Electrocardiographic Criteria | Diagnostic Sensitivity & Specificity |
|---|---|---|
| Cornell Voltage-Duration Product | $(R_{aVL} + S_{V3}) \times QRS\text{ duration} > 2440\text{ mm}\cdot\text{ms}$ (in women add $8\text{ mm}$ to $R_{aVL}$ amplitude). | Highest sensitivity ($\sim 40\%$) with high specificity ($>95\%$). |
| Sokolow-Lyon Index | $S_{V1} + R_{V5} \text{ or } R_{V6} \ge 35\text{ mm}$, or $R_{aVL} \ge 11\text{ mm}$. | Specificity $98\%$, but sensitivity $<25\%$. |
| Romhilt-Estes Point Score | Score $\ge 5$ = Definite LVH; Score $4$ = Probable LVH. - Amplitude ($R/S$ in limb leads $\ge 20\text{ mm}$ or $S_{V1/V2} \ge 30\text{ mm}$): 3 pts - ST-T strain pattern (without digitalis): 3 pts - Left atrial enlargement (Morris index): 3 pts - Left axis deviation ($\le -30^\circ$): 2 pts - QRS duration $\ge 90\text{ ms}$: 1 pt - Intrinsicoid deflection in $V_5-V_6 \ge 50\text{ ms}$: 1 pt | Comprehensive multi-parametric score. |
3. Right Ventricular Hypertrophy (RVH)
- Myers & Sokolow Criteria:
- $R/S$ ratio in lead $V_1 > 1.0$.
- $R$ wave in $V_1 \ge 7\text{ mm}$.
- $S$ wave in $V_5$ or $V_6 \ge 7\text{ mm}$.
- Right Axis Deviation ($>+90^\circ$).
- Right Ventricular Strain Pattern (ST depression and T-wave inversion in $V_1 - V_3$).
4. Multimodality Diagnostic Investigations
- Transthoracic Echocardiography (TTE): Calculates Left Ventricular Mass Index (LVMI: LVH defined as $>115\text{ g/m}^2$ in men, $>95\text{ g/m}^2$ in women) and Relative Wall Thickness (RWT: $>0.42$ defines concentric hypertrophy).
- Cardiac MRI: Most accurate standard for volumetric myocardial mass quantification.
5. Evidence-Based Clinical Management Protocols
- Intensive Antihypertensive Therapy: Angiotensin Receptor Blockers (ARBs) and ACE inhibitors promote the greatest degree of LVH electrocardiographic and anatomical regression.
- Anticoagulation in Bayés Syndrome: Prophylactic oral anticoagulation (DOACs) considered in advanced interatrial block with high CHA2DS2-VASc scores to prevent embolic stroke.